DKSH PHARMA VIETNAM CO. LTD.

DKSH PHARMA VIETNAM CO. LTD., a wholly foreign-owned enterprise established on November 24, 2017, operates as a key distribution hub for pharmaceutical and healthcare products in Vietnam. Registered under the Business ID 3702621123 with the Binh Duong Province Department of Planning and Investment, the company is headquartered at No. 23, Doc Lap Boulevard, in the Vietnam–Singapore Industrial Park, Thuan An City. A subsidiary of DKSH Holding (S) Pte. Ltd. (Singapore), the company is managed by Mr. Phillip Alexander Wray, an Australian national, with Ms. Truong Thi Lan Anh serving as Chief Accountant.

In 2023, DKSH PHARMA VIETNAM CO. LTD. reported USD 313.75 million in revenue, a 6.05% increase from 2022. Profits jumped significantly by 157.6% year-over-year to reach USD 4.12 million, while total assets declined by 20.53% to USD 167.07 million—a figure that may reflect tighter inventory or asset optimization strategies. The company’s equity stood at USD 12.81 million, with a solid working capital of USD 12.21 million, indicating a stable financial footing despite macroeconomic pressures.

While positioned as a reliable logistics and distribution partner in the healthcare sector, DKSH PHARMA VIETNAM CO. LTD. has yet to expand beyond its core functions of importing, storing, and distributing. Registered with just 100 employees, the company maintains a lean operational model, supported by offices in both Binh Duong and Ho Chi Minh City. Its role within DKSH Group’s regional supply chain remains crucial, and its steady growth affirms its place as a dependable partner in Vietnam’s evolving pharmaceutical and healthcare logistics ecosystem.